gadolinium dtpa has been researched along with pyridoxal phosphate in 33 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (pyridoxal phosphate) | Trials (pyridoxal phosphate) | Recent Studies (post-2010) (pyridoxal phosphate) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 6,511 | 140 | 860 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | pyridoxal phosphate (IC50) |
|---|---|---|---|
| P2X purinoceptor 1 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (45.45) | 18.2507 |
| 2000's | 13 (39.39) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
| Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Muller, HH; Rubin, DL; Young, SW | 1 |
| Bernardino, ME | 1 |
| Golman, K; Holtz, E; Klaveness, J; Leander, P; Leunbach, I; Olsson, M | 1 |
| Higgins, CB; Saeed, M; Wendland, MF | 1 |
| Baert, AL; Marchal, G; Ni, Y; Van Hecke, P; Yu, J; Zhang, X | 1 |
| Kettritz, U; Semelka, RC | 1 |
| Hua, J; Khangure, MS | 1 |
| Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM | 1 |
| Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Wilbur, K | 1 |
| Kopp, AF; Laniado, M | 1 |
| Diehl, SJ; Gaa, J; Georgi, M; Hoffmann, V; Lehmann, KJ; McGill, S | 1 |
| Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
| Flemming, P; Galanski, M; Högemann, D; Kreipe, H | 1 |
| De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
| Helmberger, T; Semelka, RC | 1 |
| Hahn, PF; Kalra, MK; Michael, M; Sahani, DV; Saini, S | 1 |
| Adriaens, P; Bogaert, J; Bosmans, H; Cresens, E; Dymarkowski, S; Marchal, G; Ni, Y; Verbruggen, A; Zhang, H | 1 |
| Ba-Ssalamah, A; Helbich, T; Kurtaran, A; Laengle, F; Linnau, KF; Mann, FA; Reimer, P; Ryan, M; Schibany, N; Schima, W; Schmook, MT; Wrba, F | 1 |
| Harnish, P; Lanigan, T; Li, W; Prasad, PV; Rofsky, NM; Seoane, P; Storey, P; Zuo, CS | 1 |
| Reimer, P; Schima, W; Schneider, G | 1 |
| Harnish, PP; Hu, J; Rofsky, NM; Seoane, PR; Zuo, CS | 1 |
| Kim, CS; Lee, JM; Youk, JH | 1 |
| Rummeny, EJ; Settles, M; Weirich, G; Wiener, E; Woertler, K | 1 |
| Berry, M; Brekken, C; Goa, PE; Haraldseth, O; Kovalev, V; Olsen, Ø; Petrou, M; Sandvig, A; Thuen, M | 1 |
| Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
| Ba-Ssalamah, A; Gruenberger, T; Kaczirek, K; Kulemann, V; Schima, W; Tamandl, D; Weber, M; Wrba, F | 1 |
| Bertin, A; Felder-Flesch, D; Gallani, JL; Michou-Gallani, AI | 1 |
| Bae, K; Cho, JM; Choi, DS; Choi, HC; Choi, HY; Chung, SH; Jeon, KN; Kim, JE; Na, JB; Park, MJ | 1 |
| Betts-Henderson, J; Cleary, JO; Lythgoe, MF; McCue, K; Norris, FC; Salomoni, P; Scambler, PJ; Siow, BM; Walker-Samuel, S; Wells, JA | 1 |
| Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
8 review(s) available for gadolinium dtpa and pyridoxal phosphate
| Article | Year |
|---|---|
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
Contrast-enhanced MR imaging of the pancreas.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Organometallic Compounds; Pancreas; Pancreas Transplantation; Pancreatic Diseases; Pancreatic Neoplasms; Pentetic Acid; Pyridoxal Phosphate | 1996 |
[Current status of the clinical development of MR contrast media].
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Iron; Lymphography; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 1997 |
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
3 trial(s) available for gadolinium dtpa and pyridoxal phosphate
| Article | Year |
|---|---|
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1999 |
Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers.
Topics: Adult; Bile Ducts; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Male; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2012 |
22 other study(ies) available for gadolinium dtpa and pyridoxal phosphate
| Article | Year |
|---|---|
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
Topics: Animals; Barium Sulfate; Contrast Media; Digestive System; Dogs; Edetic Acid; Ferric Compounds; Fluoroscopy; Gadolinium; Gadolinium DTPA; Gastrointestinal Transit; Image Enhancement; Magnetic Resonance Imaging; Manganese; Models, Structural; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Quaternary Ammonium Compounds | 1992 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms; Manganese; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1991 |
MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Topics: Animals; Cholestasis; Chromium; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
Magnetic resonance contrast media for myocardial imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats | 1990 |
Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Topics: Angiography; Animals; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Manganese; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Wistar | 1993 |
Comparative assessment of gadoxetate disodium, manganese dipyridoxal diphosphate, and superparamagnetic iron oxide for enhancement of the liver in dogs.
Topics: Animals; Contrast Media; Dogs; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium DTPA; Image Enhancement; Iron; Kidney; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Oxides; Pentetic Acid; Pyridoxal Phosphate; Sex Factors | 1996 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver Diseases; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pancreas; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 1996 |
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma.
Topics: Adult; Aged; Angiomyolipoma; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2001 |
Liver lesion detection and characterization with sequential use of hepatobiliary contrast agent mangafodipir trisodium and gadolinium-DTPA in a single imaging protocol.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pyridoxal Phosphate; Statistics, Nonparametric | 2002 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; Mesoporphyrins; Metalloporphyrins; Myocardial Infarction; Necrosis; Organic Chemicals; Pyridoxal Phosphate; Rats; Rhabdomyosarcoma; Swine; Tissue Distribution | 2002 |
Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Pyridoxal Phosphate; Retrospective Studies | 2002 |
T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Topics: Animals; Aorta; Contrast Media; Edetic Acid; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Swine | 2002 |
MR imaging of the stomach: potential use for mangafodipir trisodium--a study in swine.
Topics: Animals; Contrast Media; Drug Evaluation, Preclinical; Duodenogastric Reflux; Edetic Acid; Gadolinium DTPA; In Vitro Techniques; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Stomach; Swine | 2004 |
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Pyridoxal Phosphate; ROC Curve; Sensitivity and Specificity | 2004 |
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents.
Topics: Animals; Arthrography; Cartilage, Articular; Cattle; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Patellar Ligament; Pyridoxal Phosphate; Sodium Chloride; Time Factors | 2007 |
Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Topics: Analysis of Variance; Animals; Chlorides; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Imaging, Three-Dimensional; Injections; Magnetic Resonance Imaging; Manganese Compounds; Optic Nerve; Pyridoxal Phosphate; Rats; Rats, Inbred F344; Regression Analysis; Tissue Distribution; Vitreous Body | 2008 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |
Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Fatty Liver; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pyridoxal Phosphate; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
In vitro neurotoxicity of magnetic resonance imaging (MRI) contrast agents: influence of the molecular structure and paramagnetic ion.
Topics: Animals; Cells, Cultured; Contrast Media; Edetic Acid; Gadolinium DTPA; Lactate Dehydrogenases; Magnetic Resonance Imaging; Neurons; Pyridoxal Phosphate; Rats | 2010 |
Enhanced tissue differentiation in the developing mouse brain using magnetic resonance micro-histology.
Topics: Animals; Brain; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Pyridoxal Phosphate; Reproducibility of Results; Sensitivity and Specificity | 2013 |